A carregar...
FGFR-gerichtete Therapie von Kopf-Hals-Karzinomen
BACKGROUND: Genomic aberrations (mutations, gene fusions, amplifications) and dysregulation of the fibroblast growth factor (FGF) receptor (FGFR) signaling pathway are frequently found in squamous cell carcinomas of the head and neck (HNSCCs). Targeted therapy with tyrosine kinase inhibitors (TKIs)...
Na minha lista:
| Publicado no: | HNO |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Medizin
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7902560/ https://ncbi.nlm.nih.gov/pubmed/32519203 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00106-020-00893-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|